1. Home
  2. VCEL vs EPAC Comparison

VCEL vs EPAC Comparison

Compare VCEL & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • EPAC
  • Stock Information
  • Founded
  • VCEL 1989
  • EPAC 1910
  • Country
  • VCEL United States
  • EPAC United States
  • Employees
  • VCEL N/A
  • EPAC N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • EPAC Industrial Machinery/Components
  • Sector
  • VCEL Health Care
  • EPAC Technology
  • Exchange
  • VCEL Nasdaq
  • EPAC Nasdaq
  • Market Cap
  • VCEL 2.8B
  • EPAC 2.3B
  • IPO Year
  • VCEL 1997
  • EPAC N/A
  • Fundamental
  • Price
  • VCEL $59.07
  • EPAC $44.29
  • Analyst Decision
  • VCEL Strong Buy
  • EPAC
  • Analyst Count
  • VCEL 7
  • EPAC 0
  • Target Price
  • VCEL $62.29
  • EPAC N/A
  • AVG Volume (30 Days)
  • VCEL 424.2K
  • EPAC 407.5K
  • Earning Date
  • VCEL 02-27-2025
  • EPAC 12-18-2024
  • Dividend Yield
  • VCEL N/A
  • EPAC 0.09%
  • EPS Growth
  • VCEL N/A
  • EPAC 63.65
  • EPS
  • VCEL 0.07
  • EPAC 1.65
  • Revenue
  • VCEL $226,844,000.00
  • EPAC $592,736,000.00
  • Revenue This Year
  • VCEL $23.82
  • EPAC $7.71
  • Revenue Next Year
  • VCEL $22.51
  • EPAC $7.87
  • P/E Ratio
  • VCEL $821.76
  • EPAC $28.20
  • Revenue Growth
  • VCEL 22.48
  • EPAC N/A
  • 52 Week Low
  • VCEL $38.69
  • EPAC $29.42
  • 52 Week High
  • VCEL $61.49
  • EPAC $51.91
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 57.96
  • EPAC 55.33
  • Support Level
  • VCEL $53.00
  • EPAC $40.38
  • Resistance Level
  • VCEL $60.93
  • EPAC $41.34
  • Average True Range (ATR)
  • VCEL 2.60
  • EPAC 1.01
  • MACD
  • VCEL -0.06
  • EPAC 0.45
  • Stochastic Oscillator
  • VCEL 76.54
  • EPAC 99.06

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in various therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.

Share on Social Networks: